NVCR NovoCure Ltd
7,325
$16.13
$0.10
(0.62%)
| Watchers | 7,325 |
| 52-Wk Low | $10.87 |
| 52-Wk High | $83.60 |
| Market Cap | $1.73B |
| Volume | 1.14M |
| 52-Wk High | $83.60 |
| 52-Wk Low | $10.87 |
Unveiling 8 Analyst Insights On NovoCureBenzinga • 7 days ago
Latest Ratings for NVCR
DateFirmActionFromTo Feb 2022Loop CapitalInitiates Coverage OnBuy Feb 2022OppenheimerUpgradesPerformOutperform Jan 2022Truist SecuritiesUpgradesHoldBuy
View More...
Share to Feed
Futures Rise As Dovish Fed Boosts Sentiment, Reverse Bizarre Post-Powell Slide
After a bizarre reversal when US stocks first slumped and then dumped after Powell's very dovish FOMC...
Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. The...
Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2024. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of...
Novocure (NASDAQ: NVCR) today announced 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2024, to...
NovoCure Limited (NASDAQ:NVCR - Get Free Report)'s share price gapped down prior to trading on Wednesday after Wells Fargo Company lowered their price target on the stock from $49.00 to...
Vanguard Group Inc. trimmed its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 0.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional...
This is a signal that NVCR's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a Bullish indicator signaling NVCR's price could rise from here. Traders may explore going long the stock or buying call options...
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Novocure management will...